Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde from Antwerpen, company number BE0697568372, closed financial year 2025 with a result of € 393,673 after tax. For that financial year Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde recorded a gross margin of € 666,385 and equity of € 20,460. Compared with financial year 2024, the result moved from € 388,893 to € 393,673. Profitable, and profit is growing. The buffer shrank hard: equity is 95 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.
€ 20,460
▼ 95% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 393,673
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 312,679
▼ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 782,566 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 7,428
▲ 35% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 905,835
▲ 32% vs 2024
€ 92,699 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 13,009
▲ 109% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 28,869
▲ 116% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 535,782 | € 550,288 | € 642,365 | € 666,385 | ▲ 4% |
| Profit after taxes | € 327,884 | € 297,244 | € 388,893 | € 393,673 | ▲ 1% |
| Equity | € 348,344 | € 318,588 | € 409,353 | € 20,460 | ▼ 95% |
| Total debts | € 711,366 | € 813,078 | € 956,206 | € 1,473,003 | ▲ 54% |
| Cash | € 407,010 | € 11,584 | € 524,901 | € 312,679 | ▼ 40% |
| Land & buildings | - | € 399,806 | € 379,706 | € 359,606 | ▼ 5% |
| Retained profit | € 329,744 | € 299,988 | € 390,753 | € 1,860 | ▼ € 388,893 |
| Dividend | € 673,392 | € 327,000 | € 298,128 | € 782,566 | ▲ 162% |
| Bank debt | € 421,467 | € 760,435 | € 686,394 | € 905,835 | ▲ 32% |
| Balance sheet total | € 1,059,710 | € 1,131,666 | € 1,365,559 | € 1,493,463 | ▲ 9% |
Key figures of Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde?
What happened at Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 393,673 (▲ 1% vs 2024). Source: NBB ↗
- Karel Carpentier became a director. NBB
- New establishment in Antwerpen. KBO
- Liesbet Vermeiren became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 327,884 profit in 2022 to € 393,673 profit in 2025.
Paid € 453,163 in corporate taxes since 2022.
Best year ever: 2025, with € 393,673 profit.
Paid out € 2.1 million in dividends to the owners in total.
A new publication or filing at Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde? We notify you, reason included.
Follow Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkundeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde are Karel Carpentier and Liesbet Vermeiren.
Directors
According to the 2025 annual accounts
Karel Carpentier
Director
since 2020
Liesbet Vermeiren
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Vijverlaan 9
2610 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0697.568.372
- VAT number
- BE 0697.568.372
- Registered office
- Vijverlaan 9, 2610 Antwerpen
- Names & denominations
- Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 June 2018
- Peppol
- Active · Active since 27 Nov 2025